Regen BioPharma Inc | Business Contracts

Sublease Agreement (Filed With SEC on January 14, 2022)

BIOTECH ResearchGroup SCOPEOF WORK ( SOW) ORDER (Filed With SEC on October 19, 2021)

Settlement and Release Agreement (Filed With SEC on September 24, 2021)

Promissory Note (Filed With SEC on September 24, 2021)

SETTLEMENT AGREEMENT (Filed With SEC on September 16, 2021)

REGEN BIOPHARMA, INC (Filed With SEC on April 16, 2021)

KCL Agreement (Filed With SEC on April 8, 2021)

Regen Agreement (Filed With SEC on April 8, 2021)

AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND TODD S. CAVEN (Filed With SEC on March 25, 2021)

(Filed With SEC on December 18, 2019)

Form of Amendment Convertible Note (Filed With SEC on August 29, 2019)

Form of Convertible Note $20,331 (Filed With SEC on August 29, 2019)

Form of Convertible Note $14,819 (Filed With SEC on August 29, 2019)

Form of Convertible Note $100,000 (Filed With SEC on August 29, 2019)

Form of Convertible Note 50,000 (Filed With SEC on August 29, 2019)

Form of Convertible Note $63,000 (Filed With SEC on February 12, 2019)

Form of Note Receivable $50,000 (Filed With SEC on February 12, 2019)

Form of Convertible Note $50,000 (Filed With SEC on February 12, 2019)

Form of Note Receivable $63,000 (Filed With SEC on February 12, 2019)

Form of Convertible Note $75,000 (Filed With SEC on February 12, 2019)

Form of Convertible Note $63,000 (Filed With SEC on February 12, 2019)

AGREEMENT BY AND BETWEEN KCL THERAPEUTICS, INC. AND HARRY LANDER (Filed With SEC on January 25, 2019)

Regen BioPharma Inc (23)